Association of Genetic Polymorphisms of Multidrug Resistance Protein (MDR) with Clinical Outcomes in Colchicine Intoxication


UYSAL YAZICI M., BABAOĞLU M. Ö., MÜDERRİSOĞLU A., BAYRAKCİ B.

EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, no.4, pp.443-449, 2024 (ESCI) identifier

Abstract

Objectives: The current study aimed to investigate the question that if the genetic polymorphisms of MDR1 could be a contributing factor in prognosis of colchicine poisoned patients. For this purpose, we examined clinically significant MDR1 genetic polymorphisms in patients with colchicine intoxication and their relationship with treatment outcomes. Methods: MDR1 polymorphisms were studied in the blood samples collected from patients with intake of subtoxictoxic-lethal doses of colchicine before plasma or whole blood exchange between years 2013- 2018. Results: A total of 17 patients were included in the study. Median age was 15 years (min:1-max:17). Mean dose of colchicine was 0.52 +/- 0.2 mg/kg. Activated charcoal and gastric lavage was performed to all of the patients and granulocyte colony stimulating factor was given to 8 (47.1 %) patients. Two (11.8 %) of the 17 patients died. Whole blood exchange was performed in 11 ( 64.7%) patients. Extracorporeal membrane oxygenation was performed to 2 (11.8%) patients. For 1236C>T genotypes, wild type, heterozygous (CT) and homozygous mutant genotypes were demonstrated in 1 (5.9%), 11 (64.7%) and 5 (29.4%) patients, respectively. For 2677G>T/A genotype heterozygous (GT) and homozygous mutant (TT) genotypes were demonstrated in 10 (58.8 %) and 7 (41.2%) patients respectively. For 3435C>T polymorphism, wild type, heterozygous (CT) and homozygous genotypes were demonstrated in 1 (0.9 %), 10 (58.8%) and 6 (35.3%) patients, respectively. Five (29.4%) out of 17 patients had combined TT-TT-TT homozygous genotypes for the polymorphisms of MDR11236C>T, 2677G>T/A, 3435C>T and two of these five patients died. The rate (40%) of died two patients carrying homozygous (TT-TT-TT) mutant haplotypes compared with rate (0%) of none of died twelve patients having heterozygous (CT or GT) mutant haplotypes was borderline significant (40% vs 0%, p=0.07). Conclusion: Two patients who died due to colchicine intoxication were homozygous carriers of the variant alleles with TT-TT-TT haplotype. Colchicine toxicity might lead to worse consequences including increased mortality in patients who are homozygous carriers of MDR1 polymorphic alleles.